S. Guerrero-Rodríguez

Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells

S. Pérez-Tapia, M. Velasco-Velázquez, A. Segura-Cabrera, 2016, Oncotarget.

Role of CD36 in cancer progression, stemness, and targeting

S. Pérez-Tapia, M. Velasco-Velázquez, S. Guerrero-Rodríguez, 2022, Frontiers in Cell and Developmental Biology.

Gpn3 Is Essential for Cell Proliferation of Breast Cancer Cells Independent of Their Malignancy Degree

M. R. Calera, S. Guerrero-Rodríguez, R. Sánchez-Olea, 2019, Technology in cancer research & treatment.

CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion.

Amy R. Peck, J. Gray, H. Rui, 2018, Cancer research.

Targeting effector pathways in RAC1P29S-driven malignant melanoma

J. Chernoff, D. Araiza-Olivera, Cristina Uribe-Alvarez, 2019, bioRxiv.

Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug

A. González-Arenas, S. Pérez-Tapia, M. Velasco-Velázquez, 2019, Pharmacological reports : PR.

Continuous exposure to doxorubicin induces stem cell-like characteristics and plasticity in MDA-MB-231 breast cancer cells identified with the SORE6 reporter.

M. Velasco-Velázquez, N. Salinas-Jazmín, S. Guerrero-Rodríguez, 2024, Cancer chemotherapy and pharmacology.